Marie Jachiet, MD a, ⁎ , Stéphanie Harel, MD b, Anne Saussine, MD a, Maxime Battistella, MD, PhD c, d, Michel Rybojad, MD a, Bouchra Asli, MD b, Djaouida Bengoufa, MD e, Thibault Mahevas, MD a, Didier Bessis, MD, PhD f, Lionel Galicier, MD g, Jean-Luc Schmutz, MD, PhD h, Smail Hadj-Rabia, MD, PhD i, David Boutboul, MD, PhD g, Céleste Lebbé, MD, PhD a, d, Martine Bagot, MD, PhD a, d, Marion Malphettes, MD g, Dan Lipsker, MD, PhD j, Jean-Paul Fermand, MD, PhD b, Jean-David Bouaziz, MD, PhD a, d, Bertrand Arnulf, MD, PhD b, d
on behalf of theStudy Group of Systemic Diseases in Dermatology (Étude des Maladies Systémiques en Dermatologie)
Groupe d'Etude des Dermatoses Associées à une Immunoglobuline Monoclonale
a Dermatology Department, Assistance Publique Hôpitaux de Paris, Saint-Louis Hospital, Paris, France
b Immuno-hematology Department, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
c Pathology Department, Saint-Louis Hospital, Paris, France
d Université Paris Diderot-Paris VII, Sorbonne Paris Cité, France
e Immunobiology Department, Saint-Louis Hospital, Paris, France
f Dermatology Department, Saint-Eloi Hospital, University Hospital of Montpellier, France
g Clinical Immunology Department, Saint-Louis Hospital, Paris, France
h Dermatology Department, Nancy University Hospital, France
i Dermatology Department, Necker Hospital, Paris, France
j Dermatology Department, Strasbourg University Hospital, France